Science Explorer Interactive view Map
Company · San Diego · United States

Fate Therapeutics (United States)

In research, Fate Therapeutics (United States) stands highest in Medicine (#17,122 of 17,978 worldwide) and Health Sciences (#19,788 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Oncology — Oncology is 23.3× its share of world research.

World rank, 2022–2025
#15,139
of 28,054 · #17,350 all time
Rank in United States
#2,139
of 4,192
Research works
263
▲ 228% vs 2013–17
Citations
3.1k
11.7 per fractional work
Top-10% rate
12.0%
record average 16.5%
Open access
40%
world 28%

What is Fate Therapeutics (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #17,122 of 17,978 9.9%126
Health SciencesDomain #19,788 of 20,462 9.9%129

Each strip is that field’s whole ranked pool, with the notch where Fate Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Fate Therapeutics (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 23.3× the share of its output that it takes of world research.

  1. OncologySubfield · 23.0 works23×
← less than its size predictsmore →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.98× its world share, 19 worksBiochemistry, Geneti…Immunology and Microbiology: 13.02× its world share, 12 worksImmunology and Micro…Neuroscience: 0.58× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.36× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.29× its world share, 0 worksChemistryComputer Science: 0.19× its world share, 1 worksComputer ScienceEngineering: 0.14× its world share, 2 worksEngineeringEnvironmental Science: 0.11× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.33× its world share, 1 worksMaterials ScienceDentistry: 0.31× its world share, 0 worksDentistryHealth Professions: 0.17× its world share, 0 worksHealth ProfessionsMedicine: 2.70× its world share, 46 worksMedicineNursing: 0.47× its world share, 0 worksNursingVeterinary: 1.16× its world share, 0 worksVeterinaryArts and Humanities: 0.40× its world share, 1 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.32× its world share, 1 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychologySocial Sciences: 0.29× its world share, 3 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 13.0×. Every wedge is a field page.

Who are the top researchers at Fate Therapeutics (United States)?

Ranked on the composite score, Tom Lee, Bahram Valamehr and Michael P. Cooke lead among researchers whose main affiliation is Fate Therapeutics (United States).

  1. 1 Tom Lee United States · #262,493 worldwide 94 citations · 48 works
  2. 2 Bahram Valamehr United States · #793,343 worldwide 56 citations · 24 works
  3. 3 Michael P. Cooke United States · #838,956 worldwide 51 citations · 24 works
  4. 4 Rina M. Mbofung United States · #1,514,625 worldwide 5 citations · 16 works
  5. 5 Anthony E. Boitano United States · #1,516,461 worldwide 14 citations · 17 works
  6. 6 Jennifer Proctor United States · #1,602,601 worldwide 2 citations · 18 works
All ranked researchers at Fate Therapeutics (United States)

Which keywords describe research at Fate Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells and NK Cell Recognition.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy20▲ 151×3 topics
  2. Immunotherapy20▲ 32×7 topics
  3. Tumor Regression19▲ 196×2 topics
  4. Lymphoma18▲ 129×3 topics
  5. CAR T Cells18▲ 281×1 topic
  6. Chimeric Antigen Receptor18▲ 281×1 topic
  7. NK Cell Recognition6▲ 95×1 topic
  8. Natural Killer Cells6▲ 95×1 topic
  9. Inflammation5▲ 2.7×24 topics
  10. Monoclonal Antibodies5▲ 58×3 topics
  11. Cancer4▲ 3.5×13 topics
  12. Glycosylation3▲ 33×3 topics
  13. Cancer Therapy3▲ 5.9×7 topics
  14. Quality of Life3▲ 2.2×6 topics
  15. Immunogenicity2▲ 67×3 topics
  16. Therapeutic Antibodies2▲ 41×2 topics
  17. Cell Cycle Control2▲ 89×2 topics
  18. Phosphorylation2▲ 108×2 topics
  19. Tumor Microenvironment2▲ 6.1×7 topics
  20. Antibody Engineering2▲ 48×1 topic
  21. Biopharmaceuticals2▲ 50×2 topics
  22. Fc Receptors2▲ 48×1 topic
  23. Metabolism2▲ 5.1×5 topics
  24. Transcriptional Regulation2▲ 17×7 topics
  25. Innate Immunity2▲ 7.8×3 topics
  26. Immunity2▲ 6.0×3 topics
  27. Bioanalytical Methods2▲ 117×1 topic
  28. Biosimilars2▲ 117×1 topic
  29. Gene Therapy2▲ 12×4 topics
  30. Breast Cancer2▲ 9.2×5 topics
  31. Antigen Presentation2▲ 23×2 topics
  32. Cancer Progression2▲ 11×4 topics
  33. Cell Signaling2▲ 13×5 topics
  34. Monoclonal Antibody2▲ 40×2 topics
  35. Dendritic Cells2▲ 22×1 topic
  36. Tumor Antigen2▲ 32×1 topic
  37. Genome Engineering2▲ 28×1 topic
  38. RNA-Guided2▲ 28×1 topic
  39. 14-3-3 Proteins2▲ 330×1 topic
  40. cancer development2▲ 330×1 topic

Which research topics does Fate Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and Biosimilars and Bioanalytical Methods.

  1. 1 CAR-T cell therapy research Oncology 18 works
  2. 2 Immune Cell Function and Interaction Immunology 6 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 2 works
  5. 5 Immunotherapy and Immune Responses Immunology 2 works
  6. 6 CRISPR and Genetic Engineering Molecular Biology 2 works
  7. 7 14-3-3 protein interactions Molecular Biology 2 works
  8. 8 Renal Diseases and Glomerulopathies Nephrology 1 works
  9. 9 Pluripotent Stem Cells Research Molecular Biology 1 works
  10. 10 PI3K/AKT/mTOR signaling in cancer Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.6%not open60.4%

World: 28% of research is openly available.

with international co-authors15.8%domestic only84.2%

World: 19% is written across borders.

How has Fate Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 228% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.